STOCK TITAN

DarioHealth Corp - DRIO STOCK NEWS

Welcome to our dedicated news page for DarioHealth (Ticker: DRIO), a resource for investors and traders seeking the latest updates and insights on DarioHealth.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DarioHealth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DarioHealth's position in the market.

Rhea-AI Summary
DarioHealth Corp. to host in-person investor day in New York on October 17, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.36%
Tags
conferences
-
Rhea-AI Summary
63% of members using Dario platform saw reduction in depression and anxiety symptoms
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.69%
Tags
none
-
Rhea-AI Summary
DarioHealth Corp. presents new research at ADCES23 conference showing improved health outcomes with engagement in digital health solutions
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.04%
Tags
partnership
-
Rhea-AI Summary
DarioHealth Corp. reports financial results for Q2 2023, including a decrease in revenues but improved gross profit margin. The company highlights the growth in B2B customers and reduced operating expenses. They also announce new contracts and partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.43%
Tags
-
Rhea-AI Summary
DarioHealth Corp. (NASDAQ: DRIO) expands its agreement with a large regional health plan to provide personalized digital health solutions for members living with diabetes, in addition to its existing hypertension solution. The launch is expected in the first quarter of 2024. Dario's diabetes solution has been proven to engage members in healthier behaviors, resulting in estimated medical cost savings of $5,077 for Dario users compared to non-users.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.98%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.34%
Tags
none
DarioHealth Corp

Nasdaq:DRIO

DRIO Rankings

DRIO Stock Data

36.21M
23.92M
14.81%
29.43%
4.63%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
New York

About DRIO

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform.